Among patients with severe aortic stenosis at low surgical risk, transcatheter aortic valve replacement and surgery conferred ...

At two years of follow-up, patients with a poorly functioning tricuspid valve in the heart who received the best available medical therapy plus a ...

Medtronic says its Evolut TAVR shows strong valve performance and durable outcomes at 5 years in low-risk aortic stenosis ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced late-breaking data on five-year outcomes from the Evolut Low Risk Trial. Data shows, versus surgery, the Evolut™ ...

CHICAGO -- Transcatheter aortic valve replacement (TAVR) continued to hold its own against surgery for younger patients at ...

Findings from the first 500 patients treated with the Trilogy system met noninferiority for both safety and efficacy.

Sensydia, a clinical-stage non-invasive cardiac assessment company, announced today that University of Minnesota investigators presented positive clinical findings from a recent study evaluating the ...

In patients experiencing excessive bleeding during cardiac surgery, a concentrated blood product containing proteins that ...

CHENNAI: Born with Pierre Robin Syndrome — a rare condition causing a severely small lower jaw, limited mouth opening, and a ...

Based on interviews with Nick Rowe, innovation manager at Silver Fern Farms, chief executive and founder of Opo Bio, Dr ...

This couple spent 297 days hiking along a coastal path sleeping in a tent just like the subjects of the Gillian Anderson film ...